Dive into the innovative world of oncology research with The ConcertAI Podcast! ConcertAI uses artificial intelligence to revolutionize the clinical development...
Accelerating Healthcare Innovation with NVIDIA feat. Rory Kelleher
In the season three opener of The ConcertAI Podcast, our guest Rory Kelleher (Senior Director, Global Head of Business Development, Life Sciences) from NVIDIA delves into the transformative role of AI in healthcare and life sciences. With a rich background at NVIDIA, Rory shares insights into NVIDIA’s journey from a GPU manufacturer to a leader in AI computation. This episode explores NVIDIA’s initiatives like the Clara platform, which seamlessly integrates AI into medical imaging and genomics, significantly accelerating drug discovery and patient care processes. Rory and host, Jeff Elton, discuss the collaborative dynamics between ConcertAI and NVIDIA, focusing on innovative AI-driven models designed to revolutionize clinical trial design and execution. The future looks promising with the potential development of reasoning models and multimodal patient foundation models, poised to deliver personalized healthcare solutions more effectively. Tune in to discover how NVIDIA's technology is paving the way for advancements in life sciences.Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai
--------
44:00
Prostate Cancer Awareness with Steve Osunsami: Screening, Survival, and Breaking Stigmas
In this compelling episode of The ConcertAI Podcast, host Jeff Elton sits down with ABC's senior national correspondent, Steve Osunsami, to discuss the critical importance of prostate cancer screening and awareness. Steve shares his personal journey with prostate cancer, from initial diagnosis at age 41 to treatment and recovery. He highlights the significance of early detection, particularly for high-risk groups such as African American men, and the life-saving potential of regular PSA testing. Through his candid storytelling, Steve addresses the the challenges men face regarding prostate cancer, including the stigma around sexual function, and advocates for increased awareness and proactive health measures. This episode is a powerful reminder of the importance of self-advocacy and the need for tailored healthcare guidelines to better serve diverse populations. Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai
--------
40:40
Breaking New Ground in Prostate Cancer Research feat. Jennifer Rider and Kathryn Penney
September marks Prostate Cancer Awareness Month, and to honor this, our latest episode of the ConcertAI Podcast features a special session with top urological cancer specialists. Host Jeff Elton welcomes Jennifer Rider and Kathryn Penney to our studio in Harvard Square, Cambridge, MA. Both guests are distinguished cancer epidemiologists who bring a wealth of knowledge and experience in prostate cancer research. In this episode, you will hear about the personal journeys of our guests into the field of cancer research, the significant advancements they have contributed to, and the vital role of genetic studies in improving patient care. The discussion delves into the importance of the Gleason scoring system for determining patient prognosis and explores the integration of AI and digital pathology to enhance diagnosis and treatment strategies. This conversation is essential for anyone interested in the latest in prostate cancer research and the evolving treatment strategies that could redefine patient outcomes.Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai
--------
24:43
CancerLinQ's Transformational Role in Oncology with Dr. Robert Miller
Jeff Elton sits down with Dr. Robert Miller, Chief Medical and Science Officer at CancerLinQ, to unpack the integration of real-world data and AI in oncology care. Dr. Miller shares his journey from community practice to shaping CancerLinQ, revealing insights into the network's growth and its pivotal role in improving patient care. The episode delves into the transformation of quality measures, the burgeoning role of electronic health records, and the automation of data to enhance the quality and reach of oncological care. As CancerLinQ evolves, discover its expanding capabilities, the drive towards patient-centric care, and the influence on CancerLinQ's partnerships, particularly with ASCO. This is a must-listen for professionals seeking to understand the landscape of data-driven healthcare improvements. Tune in to explore the trajectory of oncology practice transformation with two industry leaders at the helm.Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai
--------
34:17
Evolution in Oncology Care feat. Dr. George W. Sledge, Jr.
Jeff Elton, CEO of ConcertAI, and George Sledge, CMO of Caris Life Sciences, embark on an insightful journey through the advancements in oncology. They explore the transformative power of molecular diagnostic testing and how comprehensive data sets are revolutionizing personalized medicine. Delving into topics like the rise of liquid biopsies, which enable non-invasive, next-gen sequencing, they highlight the potential for easier and safer tumor monitoring. Challenges like the limitations of analyzing small populations are addressed, emphasizing the value of large-scale, actionable databases in understanding diseases like breast cancer. They also discuss the future of molecular diagnostics in streamlining cancer prevention trials and the need to look beyond "gateway mutations" for a deeper understanding of dynamic cancer evolution. A key theme is the collaborative synergy between ConcertAI and Caris Life Sciences, emphasizing the goal of producing high-quality, meaningful data that can shape the future of oncological research and care.Interested in learning more about ConcertAI and Caris Life Science's joint offering? Download our factsheet today!Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai
Dive into the innovative world of oncology research with The ConcertAI Podcast! ConcertAI uses artificial intelligence to revolutionize the clinical development and delivery of cancer treatments, accelerating the delivery of precision oncology to patients in need. With real-world data, clinical trial matching, patient support, and more, ConcertAI is transforming the oncology landscape. These are rapidly changing fields which require very high expertise. Tune in twice a month as we bring subject matter experts together to take a deeper dive on topics of interest and relevance.To learn more about ConcertAI please visit us at www.ConcertAI.com
Ireland